Radiology Imaging

The radiology imaging channel includes technology news related to computed tomography (CT), digital radiography (DR / X-ray), ultrasound, magnetic resonance imaging (MRI), radiographic fluoroscopy (R/F), mammography, angiography, 3-D printing, contrast media injectors, molecular imaging, neurological imaging, pediatric imaging and radiation dose management. 

Published in Nature Communications, ReceptorNet is a breakthrough deep-learning algorithm that can determine hormone-receptor status - a crucial biomarker for clinicians when deciding on the appropriate treatment path for breast cancer treatment
News | Artificial Intelligence | December 14, 2020
December 14, 2020 — Imagine being a doctor and having a precocious resident permanently by your side, giving you...

JNM celebrates 60 years of nuclear medicine research. Image courtesy of Society of Nuclear Medicine and Molecular Imaging.

News | Nuclear Imaging | December 14, 2020
December 14, 2020 — The Journal of Nuclear Medicine (JNM) has issued a special supplement commemorating six decades of...
Among patients with breast cancer treated with radiotherapy, under-recognition of symptoms was common in reports of pain, pruritus, edema and fatigue, with younger patients and Black patients having significantly increased odds of symptom under-recognition, according to data presented at the 2020 San Antonio Breast Cancer Symposium

Getty Images

News | Women's Health | December 14, 2020
December 14, 2020 — Among patients with breast cancer treated with radiotherapy, under-recognition of symptoms was...
Bayer Radiology is announcing Radimetrics v3.0, the newest evolution of its enterprise dose management application.
News | Radiation Dose Management | December 11, 2020
December 11, 2020 — Bayer Radiology is announcing Radimetrics v3.0, the newest evolution of its enterprise dose...
Minority women and women in general aged 50-64 in Pennsylvania showed an increased proportion of early-stage breast cancer diagnosis since the implementation of the Affordable Care Act (ACA).

Getty Images

News | Breast Imaging | December 11, 2020
December 11, 2020 — Minority women and women in general aged 50-64 in Pennsylvania showed an increased proportion of...
For some, COVID-19 can result in severe pneumonia or even death, while others remain purely asymptomatic. A diagnostic tool could help physicians predict if a patient with COVID-19 will worsen.

Using 14 points in the lungs, researchers looked for abnormalities and assigned each spot a score out of 3 based on its severity. Adding up all the points, they found the total lung ultrasound score was higher for those who had a worsening outcome of COVID-19. Image courtesy of Umberto Sabatini

News | Coronavirus (COVID-19) | December 11, 2020
December 11, 2020 — For some, COVID-19 can result in severe pneumonia or even death, while others remain purely...
A new study finds that significant symptoms in young and Black patients are more likely to be under-recognized

Getty Images

News | Radiation Therapy | December 10, 2020
December 10, 2020 — Physicians did not recognize side effects from radiation therapy in more than half of breast cancer...
Post-neoadjuvant therapy changes in metabolic metrics from PET/MRI and morphologic metrics from CT were associated with pathologic response and overall survival in patients with pancreatic ductal adenocarcinoma

Pre-treatment (A-C) and post-treatment (D-F) images after eight cycles of systemic FOLFIRINOX and consolidative chemoradiation. Baseline CA 19-9 was 145 U/ml. Pre-treatment whole body axial fused PET/MRI showed FDG avid lesion in body of pancreas (arrow, A) with SUVmax 7.1 and SUVgluc 8.0. Lesion was hypo-enhancing on axial contrast-enhanced T1-weighted (T1W) MR image (arrow, B) from focused abdominal PET/MRI and on CT (arrow, C). Pre-treatment CT tumor volume was 10.3 cm3. Post-treatment whole body axial fused PET/MRI showed complete metabolic response (arrow D) with SUVmax 1.9 and SUVgluc 1.9. Lesion was indistinct on axial contrast-enhanced T1W MRI (arrow, E) and CT (arrow, F), and there was upstream pancreatic parenchymal atrophy. Post-treatment CT tumor volume was 0.46 cm3. There was normalization of CA 19-9. Relative change in SUVmax (ΔSUVgluc) was -73%, and relative change in SUVgluc (ΔSUVgluc) was -76%. Based on change in tumor size, response was categorized as partial response per RECIST. Relative change in tumor volume (ΔTvol) was -96%. Pathology showed major pathologic response (College of American Pathologists score 1.) Images courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | PET-MRI | December 10, 2020
December 10, 2020 — According to an open-access Editor's Choice article in ARRS' American Journal of Roentgenology (AJR...
Hyland Healthcare to implement complete imaging solution to better manage unstructured patient content
News | Enterprise Imaging | December 09, 2020
December 9, 2020 —  UK HealthCare, the campus-based healthcare system for the University of Kentucky, has chosen Hyland...
AiCure, an artificial intelligence (AI) and advanced data analytics company focused on improving clinical trials, introduced AiCure Data Intelligence, its next-generation data dashboard to empower sponsors with advanced visibility into each trial's progress via a single, holistic data hub.
News | Artificial Intelligence | December 09, 2020
December 9, 2020 — AiCure, an artificial intelligence (AI) and advanced data analytics company focused on improving...
Mixed Reality Viewer technology turns almost any work area into a virtual, interactive space strengthening 3D visualization, interaction and understanding. (Image courtesy of Brainlab).

Mixed Reality Viewer technology turns almost any work area into a virtual, interactive space strengthening 3D visualization, interaction and understanding. (Image courtesy of Brainlab).

News | Virtual and Augmented Reality | December 09, 2020
December 9, 2020 — the digital medical technology company, announced today that over 120 systems have been sold around...
An MR image of a patient in their early 20s shows nerve injury (highlighted in yellow) of the left brachial plexus in the neck. The patient experienced left arm weakness and pain after recovering from COVID-19 respiratory illness, which prompted them to see their primary care physician. As a result of the MRI findings, the patient was referred to the COVID-19 neurology clinic for treatment. Image courtesy of Northwestern University

An MR image of a patient in their early 20s shows nerve injury (highlighted in yellow) of the left brachial plexus in the neck. The patient experienced left arm weakness and pain after recovering from COVID-19 respiratory illness, which prompted them to see their primary care physician. As a result of the MRI findings, the patient was referred to the COVID-19 neurology clinic for treatment. Image courtesy of Northwestern University

News | Coronavirus (COVID-19) | December 08, 2020
December 8, 2020 — After recovering from COVID-19, some patients are left with chronic, debilitating pain, numbness or...
The medical imaging market size has the potential to grow by $17.64 billion during 2020-2024, and the market’s growth momentum will decelerate during the forecast period.

Getty Images

News | Radiology Business | December 08, 2020
December 8, 2020 — The medical imaging market size has the potential to grow by $17.64 billion during 2020-2024, and...
Earlier initial diagnosis reduces lung cancer mortality in heavy (ex-)smokers / The risk of harm from misdiagnosis or overdiagnosis is relatively low

Image courtesy of Toshiba/Canon

News | Computed Tomography (CT) | December 08, 2020
December 8, 2020 — For heavy (ex-)smokers, lung cancer screening using low-dose computed tomography (low-dose CT, LDCT...
Total medical devices industry deals for Q3 2020 worth $98.5bn were announced globally, according to GlobalData’s deals database.

Getty Images

News | Radiology Imaging | December 08, 2020
December 8, 2020 — Total medical devices industry deals for Q3 2020 worth $98.5B were announced globally, according to...
MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program #COVID19 #coronavirus

Getty Images

News | Coronavirus (COVID-19) | December 07, 2020
December 7, 2020 — An analysis of lung tissues from patients with different types of pulmonary fibrosis - including...
The FDA recently received a report that a patient’s face was burned from the metal in a face mask worn during an MRI, and reminds patients and providers that patients should not wear any metal during an MRI #COVID19 #pandemic

Getty Images

News | Magnetic Resonance Imaging (MRI) | December 07, 2020
December 7, 2020 — The U.S. Food and Drug Administration (FDA) is informing patients and health care providers that...
Images show symptomatic false-negative cancer in a 73-year-old black woman who presented with a palpable abnormality 64 days after negative screening mammography. (a) Negative screening left digital breast tomosynthesis (DBT) mammogram. (b) Diagnostic DBT mammogram shows a new palpable mass (arrow). (c) Spot-compression DBT mammogram enables confirmation of mass (arrow). (d) Ultrasound (US) image shows hypoechoic mass with angular margins. Subsequent US-guided biopsy revealed estrogen receptor- and progeste

Images show symptomatic false-negative cancer in a 73-year-old black woman who presented with a palpable abnormality 64 days after negative screening mammography. (a) Negative screening left digital breast tomosynthesis (DBT) mammogram. (b) Diagnostic DBT mammogram shows a new palpable mass (arrow). (c) Spot-compression DBT mammogram enables confirmation of mass (arrow). (d) Ultrasound (US) image shows hypoechoic mass with angular margins. Subsequent US-guided biopsy revealed estrogen receptor- and progesterone receptor-positive and human epidermal growth factor receptor 2-negative invasive ductal carcinoma. Image courtesy of Radiological Society of North America

News | Breast Imaging | December 07, 2020
December 7, 2020 — Breast cancer screening with digital breast tomosynthesis (DBT) offers significant advantages over...
16% of people believe they have developed a medical condition since the coronavirus crisis started but have not seen a doctor because they worry about getting COVID-19
News | Coronavirus (COVID-19) | December 07, 2020
December 7, 2020 — New research* from Zegami, an Oxford based medical image analysis platform, reveals that 29% of...
Videos | PET-CT | December 04, 2020
This is an example of Canon's Advanced intelligent Clear-IQ Engine (AiCE) AI-driven image reconstruction software that...